Journal
EUROPEAN RESPIRATORY JOURNAL
Volume 37, Issue 2, Pages 371-375Publisher
EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/09031936.00011910
Keywords
Procalcitonin; prognosis; pulmonary tuberculosis
Categories
Ask authors/readers for more resources
There are very few data on serum procalcitonin (PCT) levels in pulmonary tuberculosis (PTB) patients who are negative for HIV. We assessed serum PCT in consecutive patients diagnosed with pulmonary tuberculosis or community-acquired pneumonia (CAP) on admission to discriminate between PTB and CAP, and examined the value of prognostic factors in PTB. 102 PTB patients, 62 CAP patients, and 34 healthy volunteers were enrolled. Serum PCT in PTB patients was significantly lower than in CAP patients (mean +/- SD 0.21 +/- 0.49 versus 4.10 +/- 8.68 ng.mL(-1); p<0.0001). By receiver-operating characteristic curve analysis, serum PCT was an appropriate discrimination marker for PTB and CAP (area under the curve 0.866). PTB patients with >= 0.5 ng.mL(-1) (normal cut-off) had significantly shorter survival than those with <0.5 ng.mL(-1) (p<0.0001). Serum PCT is not habitually elevated in HIV-negative PTB patients and is a useful biomarker for discriminating between PTB and CAP; however, when serum PCT is outside the normal range, it is a poor prognostic marker.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available